Target intelligence / Profile preview

Neuroprotective factor

Molecular classification
Growth factor, Cytokine, Neuropeptide, Protein
01

Overview

Neuroprotective factors are a broad class of endogenous molecules, primarily proteins like neurotrophins and growth factors, that safeguard neurons from pathological insults and promote their survival and functional maintenance. These factors, including Brain-derived neurotrophic factor (BDNF), Nerve growth factor (NGF), and Glial cell line-derived neurotrophic factor (GDNF), play critical roles in the development and plasticity of the central and peripheral nervous systems (Huang & Reichardt, 2001, Annu Rev Neurosci). In many neurodegenerative conditions, such as Alzheimer's and Parkinson's diseases, there is a documented deficiency or impaired signaling of these factors, which accelerates neuronal death and cognitive or motor decline (Zuccato & Cattaneo, 2009, Nat Rev Neurol). Therapeutic strategies often focus on delivering exogenous factors, stimulating endogenous production, or using small molecules to mimic their effects. However, clinical application is frequently hindered by the difficulty of delivering these large molecules across the blood-brain barrier and the potential for off-target effects in non-neuronal tissues (Skaper, 2018, Methods Mol Biol).

Other names
Neurotrophic factorsNeuroprotectantsNeuronal survival factorsNeurotrophins
02

Mechanism of action

Neuroprotective factors function by activating pro-survival signaling pathways, such as the PI3K/Akt and MAPK/ERK pathways, which inhibit pro-apoptotic proteins and enhance the expression of antioxidant enzymes and anti-apoptotic factors like Bcl-2 (Skaper, 2018, Methods Mol Biol). They also modulate synaptic transmission, reduce neuroinflammation, and promote structural plasticity to maintain neural circuit integrity.

03

Biological functions

Neuronal survivalSynaptic plasticityNeurogenesisApoptosis inhibitionSignal transduction
04

Disease associations

Alzheimer's diseaseParkinson's diseaseAmyotrophic lateral sclerosisStrokeTraumatic brain injuryNeurodegenerative disease
05

Safety considerations

Blood-brain barrier permeabilityShort biological half-lifePotential for systemic toxicityRisk of oncogenesis due to growth-promoting effectsImmunogenicity of recombinant protein therapies
06

Interacting drugs

Memantine

4 more in the full profile.

07

Biomarkers

Brain-derived neurotrophic factor (BDNF) levelsNeurofilament light chain (NfL)S100 calcium-binding protein B (S100B)Glial fibrillary acidic protein (GFAP)

Beyond the preview

Go deeper on Neuroprotective factor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroprotective factor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call